Prevention of Influenza Virus-Induced Immunopathology by TGF-β Produced during Allergic Asthma

1. (2013) Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices—United States, 2013–2014. MMWR Recomm Rep 62: 1–43.

2. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, et al. (1995) Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 310: 1225–1229. 7767192

3. Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, et al. (2004) Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 114: 239–247. 15316497

4. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, et al. (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360: 588–598. doi: 10.1056/NEJMoa0804877 19196675

5. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, et al. (1995) Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332: 133–138. 7800004

6. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B (2000) Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161: 1501–1507. 10806145

7. O'Callaghan-Gordo C, Bassat Q, Diez-Padrisa N, Morais L, Machevo S, et al. (2013) Lower respiratory tract infections associated with rhinovirus during infancy and increased risk of wheezing during childhood. A cohort study. PLoS One 8: e69370. doi: 10.1371/journal.pone.0069370 23935997

8. Schauer U, Hoffjan S, Bittscheidt J, Kochling A, Hemmis S, et al. (2002) RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 20: 1277–1283. 12449185

9. Lemanske RF Jr., Jackson DJ, Gangnon RE, Evans MD, Li Z, et al. (2005) Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116: 571–577. 16159626

10. Damjanovic D, Small CL, Jeyanathan M, McCormick S, Xing Z (2012) Immunopathology in influenza virus infection: uncoupling the friend from foe. Clin Immunol 144: 57–69. doi: 10.1016/j.clim.2012.05.005 22673491

11. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203–1207. 16964257

12. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, et al. (2009) Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 13: R201. doi: 10.1186/cc8208 20003352

13. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319–323. 17230189

14. Taubenberger JK, Morens DM (2008) The pathology of influenza virus infections. Annu Rev Pathol 3: 499–522. 18039138

15. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, et al. (2011) Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 37: 272–283. doi: 10.1007/s00134-010-2078-z 21107529

16. Diaz E, Martin-Loeches I, Canadell L, Vidaur L, Suarez D, et al. (2012) Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect 64: 311–318. doi: 10.1016/j.jinf.2011.12.010 22240033

17. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693–699. 1436033

18. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, et al. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90: 770–774. 8421714

19. Carlson CM, Turpin EA, Moser LA, O'Brien KB, Cline TD, et al. (2010) Transforming growth factor-beta: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog 6: e1001136. doi: 10.1371/journal.ppat.1001136 20949074

20. Williams AE, Humphreys IR, Cornere M, Edwards L, Rae A, et al. (2005) TGF-beta prevents eosinophilic lung disease but impairs pathogen clearance. Microbes Infect 7: 365–374. 15784186

21. D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, et al. (2009) CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119: 2898–2913. doi: 10.1172/JCI36498 19770521

22. Antunes I, Kassiotis G (2010) Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice. J Virol 84: 12564–12575. doi: 10.1128/JVI.01559-10 20943986

23. Betts RJ, Prabhu N, Ho AW, Lew FC, Hutchinson PE, et al. (2012) Influenza A virus infection results in a robust, antigen-responsive, and widely disseminated Foxp3+ regulatory T cell response. J Virol 86: 2817–2825. doi: 10.1128/JVI.05685-11 22205730

24. Crosby LM, Waters CM (2010) Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298: L715–731. doi: 10.1152/ajplung.00361.2009 20363851

25. Buckley S, Shi W, Barsky L, Warburton D (2008) TGF-beta signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 294: L739–748. doi: 10.1152/ajplung.00294.2007 18245268

26. Yang YC, Zhang N, Van Crombruggen K, Hu GH, Hong SL, et al. (2012) Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 67: 1193–1202. doi: 10.1111/j.1398-9995.2012.02880.x 22913656

27. Watanabe J, Miyazaki Y, Zimmerman GA, Albertine KH, McIntyre TM (2003) Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J Biol Chem 278: 42361–42368. 12909619

28. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, et al. (2009) House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15: 410–416. doi: 10.1038/nm.1946 19330007

29. Shinya K, Okamura T, Sueta S, Kasai N, Tanaka M, et al. (2011) Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Virol J 8: 97. doi: 10.1186/1743-422X-8-97 21375734

30. Balk RA (2000) Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 16: 337–352, vii. 10768085

31. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24: 99–146. 16551245

32. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R (1995) Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270: 10618–10624. 7737999

33. Magnan A, Retornaz F, Tsicopoulos A, Brisse J, Van Pee D, et al. (1997) Altered compartmentalization of transforming growth factor-beta in asthmatic airways. Clin Exp Allergy 27: 389–395. 9146931

34. Vignola AM, Chanez P, Chiappara G, Merendino A, Zinnanti E, et al. (1996) Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 106: 114–119. 8870708

35. Hastie AT, Kraft WK, Nyce KB, Zangrilli JG, Musani AI, et al. (2002) Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge. Am J Respir Crit Care Med 165: 266–272. 11790666

36. Oshima M, Oshima H, Taketo MM (1996) TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179: 297–302. 8873772

37. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, et al. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121: 1845–1854. 7600998

38. Samarasinghe AE, Woolard SN, Boyd KL, Hoselton SA, Schuh JM, et al. (2014) The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol 92: 449–459. doi: 10.1038/icb.2013.113 24469764

39. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, et al. (1999) Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 159: 487–494. 9927362

40. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, et al. (1997) Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 156: 642–647. 9279252

41. Batra V, Musani AI, Hastie AT, Khurana S, Carpenter KA, et al. (2004) Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 34: 437–444. 15005738

42. Nomura A, Uchida Y, Sakamoto T, Ishii Y, Masuyama K, et al. (2002) Increases in collagen type I synthesis in asthma: the role of eosinophils and transforming growth factor-beta. Clin Exp Allergy 32: 860–865. 12047432

43. Kumar RK, Herbert C, Foster PS (2004) Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy 34: 567–575. 15080809

44. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, et al. (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12: 1045–1054. doi: 10.1031/ni.2131 21946417

45. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, et al. (2003) Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 422: 169–173. 12634787

46. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, et al. (2008) A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 9: 1074–1083. doi: 10.1038/ni.1637 18660812

47. Ishikawa H, Sasaki H, Fukui T, Fujita K, Kutsukake E, et al. (2012) Mice with asthma are more resistant to influenza virus infection and NK cells activated by the induction of asthma have potentially protective effects. J Clin Immunol 32: 256–267. doi: 10.1007/s10875-011-9619-2 22134539

48. Slifka MK, Pagarigan RR, Whitton JL (2000) NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 164: 2009–2015. 10657652

49. Lee U, Santa K, Habu S, Nishimura T (1996) Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors. Jpn J Cancer Res 87: 429–432. 8641977

50. Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, et al. (1999) Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 104: 1715–1722. 10606625

51. Wiltrout RH, Santoni A, Peterson ES, Knott DC, Overton WR, et al. (1985) Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukoc Biol 37: 597–614. 3884721

52. Kataoka S, Konishi Y, Nishio Y, Fujikawa-Adachi K, Tominaga A (2004) Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma. DNA Cell Biol 23: 549–560. 15383175

53. Nishikado H, Mukai K, Kawano Y, Minegishi Y, Karasuyama H (2011) NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo. J Immunol 186: 5766–5771. doi: 10.4049/jimmunol.1100370 21490162

54. Morris SK, Parkin P, Science M, Subbarao P, Yau Y, et al. (2012) A retrospective cross-sectional study of risk factors and clinical spectrum of children admitted to hospital with pandemic H1N1 influenza as compared to influenza A. BMJ Open 2: e000310. doi: 10.1136/bmjopen-2011-000310 22411932

55. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, et al. (2010) Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr (Phila) 49: 777–781.

56. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361: 1935–1944. doi: 10.1056/NEJMoa0906695 19815859

57. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, et al. (2010) Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362: 45–55. doi: 10.1056/NEJMoa0907673 20032320

58. Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, et al. (2012) Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med 185: 1275–1279. doi: 10.1164/rccm.201109-1635OC 22366048

59. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8: e1001053. doi: 10.1371/journal.pmed.1001053 21750667

60. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, et al. (2011) A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 52: 301–312. doi: 10.1093/cid/ciq152 21208911

61. Myles P, Nguyen-Van-Tam JS, Semple MG, Brett SJ, Bannister B, et al. (2013) Differences between asthmatics and nonasthmatics hospitalised with influenza A infection. Eur Respir J 41: 824–831. doi: 10.1183/09031936.00015512 22903963

62. Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q (2011) Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol 44: 127–133. doi: 10.1165/rcmb.2010-0027TR 20525803

63. Peters SP, Ferguson G, Deniz Y, Reisner C (2006) Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med 100: 1139–1151. 16713224

64. Busse WW, Lemanske RF Jr., Gern JE (2010) Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376: 826–834. doi: 10.1016/S0140-6736(10)61380-3 20816549

65. Furuya Y, Roberts S, Hurteau GJ, Sanfilippo AM, Racine R, et al. (2014) Asthma increases susceptibility to heterologous but not homologous secondary influenza. J Virol 88: 9166–9181. doi: 10.1128/JVI.00265-14 24899197